Scientists allover the world are still trying to study efficacy of available COVID-19 vaccines and their side effects. While it is easy to monitor short term effects, long term effects require time and substantial data.
Due to shortage of AstraZeneca vaccine and banning of importation of Sputinik vaccine to Kenya, the country is looking for alternative vaccines. Through the ministry of health, the government has said that it will import Pfizer and Johnson& Johnson vaccines. AstraZeneca Vaccine shortage has been brought by India unwillingness to export it to other countries as it battles a surge of domestic cases.
A study done by researchers in Israel has shown that shingles may be a side effect associated with Pfizer vaccine. According to the study, the rashes are five times more likely to happen after the first dose compared to the second dose. The shingles mostly affect people with autoimmune diseases according to the study.
Content created and supplied by: HotNews_Ke (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More